The study showed that treatment with encorafenib and cetuximab plus mFOLFOX6 chemotherapy significantly improved objective response rate, progression-free survival, and overall survival compared with ...
Washington — New options for testing and treating some of the most common sexually transmitted diseases are becoming available, a trend that experts hope will keep downward pressure on U.S. infection ...
WASHINGTON (AP) — New options for testing and treating some of the most common sexually transmitted diseases are becoming available, a trend that experts hope will keep downward pressure on U.S.
This photo provided by Visby Medical in January 2026 shows its three-in-one gonorrhea, chlamydia and trichomoniasis test for women. (Visby Medical via AP) (Uncredited, Visby Medical) Last year, the ...
At-home STD tests and newly approved treatments are expanding options for screening, privacy and care as U.S. infection rates decline.
You don’t need to take it with water.
Hologic, Inc. (Nasdaq: HOLX) announced today that its Aptima ® HPV Assay received FDA approval for clinician-collected HPV ...
Medical Device Network on MSN
Hologic’s Aptima assay secures FDA approval for HPV primary screening
With this FDA approval, Hologic now offers three guideline-recommended methods: Pap testing, HPV primary testing, and ...
GERMANTOWN, Md., Jan. 12, 2026 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to improve ...
The FDA has approved copper histidinate (Zycubo, Sentynl Therapeutics) injection as the first and only treatment to date, for Menkes disease in pediatric patients, the agency announced. The treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results